1 documents found
Head: . Research of phase is opened I In farmakokinetiki, farmakodinamiki and safety of glitseril tri-(-fenilbutirata), which appoint parallel as non-permanent so twice on a day during seven successive days, explored with violations of function of liver, with a cirrhosis and control group.
National University of Pharmacy. № 0106U006412
1 documents found
Updated: 2026-03-24
